BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 7706468)

  • 1. An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets. Its influence on glycoprotein IIb-IIIa complex function.
    Nurden P; Savi P; Heilmann E; Bihour C; Herbert JM; Maffrand JP; Nurden A
    J Clin Invest; 1995 Apr; 95(4):1612-22. PubMed ID: 7706468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A defect of platelet aggregation associated with an abnormal distribution of glycoprotein IIb-IIIa complexes within the platelet: the cause of a lifelong bleeding disorder.
    Hardisty R; Pidard D; Cox A; Nokes T; Legrand C; Bouillot C; Pannocchia A; Heilmann E; Hourdillé P; Bellucci S
    Blood; 1992 Aug; 80(3):696-708. PubMed ID: 1638023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrastructural studies of platelet aggregates from human subjects receiving clopidogrel and from a patient with an inherited defect of an ADP-dependent pathway of platelet activation.
    Humbert M; Nurden P; Bihour C; Pasquet JM; Winckler J; Heilmann E; Savi P; Herbert JM; Kunicki TJ; Nurden AT
    Arterioscler Thromb Vasc Biol; 1996 Dec; 16(12):1532-43. PubMed ID: 8977459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate.
    Cattaneo M; Lecchi A; Randi AM; McGregor JL; Mannucci PM
    Blood; 1992 Dec; 80(11):2787-96. PubMed ID: 1333302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colloidal gold labelling of fibrinogen receptors in epinephrine- and ADP-activated platelet suspensions.
    Oliver JA; Albrecht RM
    Scanning Microsc; 1987 Jun; 1(2):745-56. PubMed ID: 3616571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of platelet glycoprotein IIb-IIIa receptor expression and fibrinogen binding. II. Quantal activation parallels platelet capture in stir-associated microaggregation.
    Frojmovic MM; Mooney RF; Wong T
    Biophys J; 1994 Nov; 67(5):2069-75. PubMed ID: 7858144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet activation by 2-(4-bromo-2,3-dioxobutylthio)adenosine 5'-diphosphate is mediated by its binding to a putative ADP receptor, aggregin.
    Puri RN; Colman RF; Colman RW
    Eur J Biochem; 1996 Mar; 236(3):862-70. PubMed ID: 8665907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new variant of Glanzmann's thrombasthenia (Strasbourg I). Platelets with functionally defective glycoprotein IIb-IIIa complexes and a glycoprotein IIIa 214Arg----214Trp mutation.
    Lanza F; Stierlé A; Fournier D; Morales M; André G; Nurden AT; Cazenave JP
    J Clin Invest; 1992 Jun; 89(6):1995-2004. PubMed ID: 1602006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of ADP-induced platelet responses by covalent modification of aggregin, a putative ADP receptor, by 8-(4-bromo-2,3-dioxobutylthio)ADP.
    Puri RN; Kumar A; Chen H; Colman RF; Colman RW
    J Biol Chem; 1995 Oct; 270(41):24482-8. PubMed ID: 7592664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of platelet glycoprotein IIb-IIIa receptor expression and fibrinogen binding. I. Quantal activation of platelet subpopulations varies with adenosine diphosphate concentration.
    Frojmovic MM; Mooney RF; Wong T
    Biophys J; 1994 Nov; 67(5):2060-8. PubMed ID: 7858143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelets from bleeding Simmental cattle mobilize calcium, phosphorylate myosin light chain and bind normal numbers of fibrinogen molecules but have abnormal cytoskeletal assembly and aggregation in response to ADP.
    Searcy GP; Frojmovic MM; McNicol A; Robertson C; Wong T; Gerrard JM
    Thromb Haemost; 1994 Feb; 71(2):240-6. PubMed ID: 8191406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ca+2 mobilization and fibrinogen binding of platelets refractory to adenosine diphosphate stimulation.
    Peerschke EI
    J Lab Clin Med; 1985 Aug; 106(2):111-22. PubMed ID: 2991399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the binding of an alloimmune and two murine monoclonal antibodies to the platelet glycoprotein IIb-IIIa complex receptor.
    Coller BS; Peerschke EI; Seligsohn U; Scudder LE; Nurden AT; Rosa JP
    J Lab Clin Med; 1986 Apr; 107(4):384-92. PubMed ID: 2420911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggregation of chymotrypsin-treated thrombasthenic platelets is mediated by fibrinogen binding to glycoproteins IIb and IIIa.
    Niewiarowski S; Kornecki E; Hershock D; Tuszynski GP; Bennett JS; Soria C; Soria J; Dunn F; Pidard D; Kieffer N
    J Lab Clin Med; 1985 Dec; 106(6):651-60. PubMed ID: 2999274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin-induced platelet aggregates have a dynamic structure. Time-dependent redistribution of glycoprotein IIb-IIIa complexes and secreted adhesive proteins.
    Heilmann E; Hourdillé P; Pruvost A; Paponneau A; Nurden AT
    Arterioscler Thromb; 1991; 11(3):704-18. PubMed ID: 2029507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The platelet fibrinogen receptor: an immunogold-surface replica study of agonist-induced ligand binding and receptor clustering.
    Isenberg WM; McEver RP; Phillips DR; Shuman MA; Bainton DF
    J Cell Biol; 1987 Jun; 104(6):1655-63. PubMed ID: 3584243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficiency of (33P)2MeS-ADP binding sites on platelets with secretion defect, normal granule stores and normal thromboxane A2 production. Evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A2 production.
    Cattaneo M; Lombardi R; Zighetti ML; Gachet C; Ohlmann P; Cazenave JP; Mannucci PM
    Thromb Haemost; 1997 May; 77(5):986-90. PubMed ID: 9184415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen.
    Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S
    J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of two structurally and functionally distinct sites on human platelet membrane glycoprotein IIb-IIIa using monoclonal antibodies.
    McEver RP; Bennett EM; Martin MN
    J Biol Chem; 1983 Apr; 258(8):5269-75. PubMed ID: 6220015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The thienopyridine ticlopidine selectively prevents the inhibitory effects of ADP but not of adrenaline on cAMP levels raised by stimulation of the adenylate cyclase of human platelets by PGE1.
    Gachet C; Cazenave JP; Ohlmann P; Bouloux C; Defreyn G; Driot F; Maffrand JP
    Biochem Pharmacol; 1990 Dec; 40(12):2683-7. PubMed ID: 2175608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.